Related Experiment Video
Updated: Mar 25, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Implementing Treat-to-Target Practices for Chronic Pain Through Shared Decision Making: Requisites, Prospects, and
1VA Connecticut Healthcare System, Clinical Epidemiology Research Center, West Haven, Connecticut, U.S.A.
Patient disease activity scores, not beliefs, directly influence willingness to change chronic pain treatments. This supports patient involvement in treat-to-target (T2T) strategies for rheumatoid arthritis management.
Area of Science:
- Rheumatology
- Clinical Psychology
- Pain Management
Background:
- Treat-to-target (T2T) is a collaborative approach for managing chronic pain, involving goal setting, symptom assessment, and treatment adjustment.
- Patient participation in T2T has been questioned, but empirical evidence is lacking.
- Understanding factors influencing patient willingness to modify treatment is crucial for effective T2T implementation.
Purpose of the Study:
- To investigate the impact of patient-assessed disease activity (DA) and illness beliefs on their willingness to alter current treatments.
- To empirically assess patient capacity for collaborative decision-making in chronic pain management.
Main Methods:
- 157 rheumatoid arthritis patients completed assessments of disease activity (pain, function) and illness beliefs over six months.
- Willingness to change treatment was measured alongside disease activity and belief questionnaires.
- Linear mixed models were used to analyze the relationships between these variables.
Main Results:
- Willingness to change treatment showed a strong, direct association with disease activity scores.
- Illness beliefs did not significantly influence willingness to change when disease activity was considered.
- The number of self-reported symptoms directly correlated with the willingness to modify treatment.
Conclusions:
- Concerns regarding patient ability to participate in collaborative T2T were not supported by the findings.
- Disease activity, particularly self-reported symptoms, is a primary driver of treatment change willingness.
- Future research should explore the nuanced interactions within clinical decision-making processes for T2T.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Analgesia and Pain Management
Therapeutic Drug Monitoring: Affecting Factors
Combination Therapies and Personalized Medicine
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Peripheral Artery Disease III: Interprofessional Care

